These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Primary vaccination of infants with diphtheria-tetanus-acellular pertussis-hepatitis B virus- inactivated polio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections. Schmitt HJ, Knuf M, Ortiz E, Sänger R, Uwamwezi MC, Kaufhold A. J Pediatr; 2000 Sep; 137(3):304-12. PubMed ID: 10969252 [Abstract] [Full Text] [Related]
8. Immunogenicity and reactogenicity of a combined fully liquid DTPw-HepB-Hib pentavalent vaccine in healthy infants: no clinically relevant impact of a birth dose of hepatitis B vaccine. Gentile A, Umido V, Czerniuk P, Nacul J, Seigelchifer M, Hilbert AK, Yela U, Herzog C, Aeberhard U, Spyr C. Int J Infect Dis; 2011 Jan; 15(1):e24-9. PubMed ID: 21093342 [Abstract] [Full Text] [Related]
9. Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age. Nolan T, Bernstein H, Blatter MM, Bromberg K, Guerra F, Kennedy W, Pichichero M, Senders SD, Trofa A, Collard A, Sullivan DC, Descamps D. Pediatrics; 2006 Sep; 118(3):e602-9. PubMed ID: 16950952 [Abstract] [Full Text] [Related]
11. Safety and immunogenicity of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 3, 4, and 12-14 months of age. Halperin SA, Tapiero B, Diaz-Mitoma F, Law BJ, Hoffenbach A, Zappacosta PS, Radley D, McCarson BJ, Martin JC, Brackett LE, Boslego JW, Hesley TM, Bhuyan PK, Silber JL. Vaccine; 2009 Apr 28; 27(19):2540-7. PubMed ID: 19124057 [Abstract] [Full Text] [Related]
14. Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine. Tejedor JC, Moro M, Ruiz-Contreras J, Castro J, Gómez-Campderá JA, Navarro ML, Merino JM, Martín-Ancel A, Roca J, García-del-Río M, Jurado A, Díez-Delgado FJ, Omeñaca F, García-Sicilia J, Boceta R, García-Corbeira P, Jacquet JM, Collard A, Schuerman L, Spanish DTaP-HBV-IPV-097 Study Group. Pediatr Infect Dis J; 2006 Aug 28; 25(8):713-20. PubMed ID: 16874171 [Abstract] [Full Text] [Related]
15. Safety and immunogenicity of a primary course and booster dose of a combined diphtheria, tetanus, acellular pertussis, hepatitis B and inactivated poliovirus vaccine. Meriste S, Lutsar I, Tamm E, Willems P. Scand J Infect Dis; 2006 Aug 28; 38(5):350-6. PubMed ID: 16709537 [Abstract] [Full Text] [Related]
16. [Study on immune persistency of combined diphtheria-pertussis-tetanus (DPT) triple vaccine]. Diao L. Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Feb 28; 13(1):26-9. PubMed ID: 1581951 [Abstract] [Full Text] [Related]
17. [Evaluation of the reactogenicity and immunogenic potency of combined vaccine "Bubo-Kok" in the immunization of children against diphtheria, tetanus, pertussis and viral hepatitis B]. Fel'dblium IV, Nikolaeva AM, Kuz'ianin AV, Borisova VN, Mel'nikov VA, Chuprinina RP, Perelygina OV, Shalunova NV, Semenova VD, Griaznova DV, Pushkareva EV, Uvitskiĭ AIu, Alekseeva IA, Konopleva OA, Budanov MV, Iakovleva IM. Zh Mikrobiol Epidemiol Immunobiol; 2004 Feb 28; (5):58-62. PubMed ID: 15554315 [Abstract] [Full Text] [Related]
20. Evaluation of immunity status to routine vaccination in pediatric liver transplant candidates. Dehghani SM, Shakiba MA, Ziaeyan M, Imanieh MH, Haghighat M, Sedaghat M, Alborzi A, Malek-Hosseini SA. Turk J Gastroenterol; 2014 Dec 28; 25 Suppl 1():26-31. PubMed ID: 25910330 [Abstract] [Full Text] [Related] Page: [Next] [New Search]